Latest Articles
- ArticleRegional microglial activation in the substantia nigra is linked with fatigue in MSTarun Singhal, Steven Cicero, Hong Pan, et al.August 07, 2020
- ArticleValidation of the NEOS score in Chinese patients with anti-NMDAR encephalitisYujing Peng, Feifei Dai, Lei Liu, et al.August 05, 2020
- ArticleHigh-throughput investigation of molecular and cellular biomarkers in NMOSDSoumya S. Yandamuri, Ruoyi Jiang, Aditi Sharma, et al.August 04, 2020
- ArticleTailoring B cell depletion therapy in MS according to memory B cell monitoringGiovanni Novi, Francesca Bovis, Sabrina Fabbri, et al.August 04, 2020
- ArticleEffect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MSSarah Harris, Jonathan Q. Tran, Harry Southworth, et al.July 31, 2020
- ArticleTreatment and outcome of aquaporin-4 antibody–positive NMOSDA multinational pediatric studyRenata Barbosa Paolilo, Yael Hacohen, Elise Yazbeck, et al.July 30, 2020
- ArticleClinically based score predicting cryptogenic NORSE at the early stage of status epilepticusAtsuko Yanagida, Naomi Kanazawa, Juntaro Kaneko, et al.July 29, 2020
- ArticleInfliximab treatment in pathology-confirmed neurosarcoidosisDaan Fritz, Wilhelmina M.C. Timmermans, Jan A.M. van Laar, et al.July 27, 2020
- ArticleAntiparanodal antibodies and IgG subclasses in acute autoimmune neuropathyLuise Appeltshauser, Anna-Michelle Brunder, Annika Heinius, et al.July 24, 2020
- EditorialIsotyping paranodal antibodies in inflammatory neuropathiesOne step closer to precision careCinta Lleixà, Luis QuerolJuly 24, 2020
Pages
Advertisement